TMCnet News
Cayenne Medical appoints new president and CEOFeb 10, 2011 (Datamonitor via COMTEX) -- Cayenne Medical, Inc., a medicine device company, has appointed David Springer as president and CEO. He will succeed James Hart who has transitioned to executive chairman due to health reasons. Hart, who has led Cayenne Medical as Chairman, President and CEO since the company's inception in 2005, will continue to work with management and the Board in guiding the strategic direction of the company. Springer, 46, joins Cayenne with over 20 years executive leadership experience in Healthcare Fortune 500, and emerging, entrepreneurial companies in the medical device industry. His significant experience includes the successful commercialization of numerous products, improved sales performance and operational strategy implementation. Most recently, Springer served as President & CEO of CHF Solutions, Inc. in Brooklyn Park, MN, where he successfully led the company to profitability and the eventual sale to Gambro, a global medical device company, in 2010. In his four years with CHF, Springer was responsible for substantially growing revenue, product utilization and penetration by developing and executing on commercialization and market development strategies. Prior to this, he served as Senior vice president of the US division of St. Jude Medical, where he had primary brand management accountability and was influential in driving the US strategic and operational plan. Previously, Springer was the COO at AnyDevice (acquired by Hiddenmind Technology). "As a founding member, I have a personal commitment and passion for Cayenne and its proven soft-tissue reconstruction technology platform," said James Hart, Executive Chairman, Cayenne Medical. "I plan to work with David to ensure a smooth transition, and am confident that his medical device leadership experience will be invaluable to the ongoing growth and success of the company, particularly as we continue to see increased surgeon demand for our AperFix System." http://www.datamonitor.com Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon |
